UAE Diabetes Industry to Receive Boost from Domestic Company's Initiatives

The UAE Diabetes industry is expected to grow at a CAGR of 10% during 2011-2013 on the back of proactive initiatives being taken by domestic companies to bridge the gap in insulin demand, says RNCOS.

Noida, India (prHWY.com) May 13, 2011 - With a high prevalence rate, diabetes is one of the most widespread health issues in the UAE. Besides, problems caused by hormonal imbalance, unhealthy lifestyle, and irregular eating habits have also majorly contributed towards this current predicament. The situation has become so grave that a large percentage of the country's youth is also suffering from this problem. Hence, these factors coupled with the rising senior population will act as massive growth drivers for the UAE Diabetes market, which is anticipated to grow at a CAGR of around 10% during 2011-2013.

According to our latest research report "Diabetes Market in UAE", there has been an impending need for the domestic pharma companies to come forward and help the UAE in coping with the lack of requisite insulin drugs. Towards this, initiatives have started flowing in with the first one being done by a leading pharma company, Gulf Pharmaceutical Industries (Julphar). The Company will start producing insulin by the end of 2011 as soon as the final phase of its Dh500 Million (US$ 136.1 Million) insulin plant is completed. The plant will help the company in producing over 40 Million vials, which will lower costs and ensure supply for the control of diabetes in the UAE.

According to a Senior Analyst at RNCOS, this development is expected to start a chain reaction in the industry, as more domestic companies will invest in the production of insulin and taking the reins away from foreign companies currently dominating the market. Through in-depth and prudent analysis of various industry factors in the UAE, we have identified the prominent developments and drivers that will take the diabetes market in the UAE to new heights. For a comprehensive overview of the diabetes market, we have studied the major segments of the market by type, by delivery devices, and by glucose monitoring.

"Diabetes Market in UAE" provides a complete overview of the diabetes care market in the country and helps in understanding the future prospects of the same. It also contains critical information about key players along with their business strategies and area of expertise. This will provide clients an additional edge over their competitors, while devising business plans.

For FREE SAMPLE of this report visit: http://rncos.com/Report/IM247.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm

About RNCOS:

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: uae diabetes market

Categories: Biotech

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code